Since Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver and…

A Stanford University spinout that lists Johnson & Johnson, Novartis and Pfizer among its users has raised $10 million to develop its brain mapping…

TG Therapeutics got orphan drug designation from the FDA for both its clinical candidates this week.

Theranos, which has come under fire over the validity of its fingerprick blood tests, announced Friday that it plans to appeal sanctions served last month by…

Gobiquity, which markets a smartphone vision screening app, reeled in $6 million in a first close of its Series B round.

Medivation loses its VP after the Pfizer buy, Shanghai Pharma loses its chairman after only three months and Sarah Jessica Parker waves goodbye to Mylan…

Belgium biotech argenx has seen its income double on the back of a strong year of deals, but has also seen fit to cut two former R&D pacts.

Struggling microcap GenVec has again been warned that it will be taken off the lucrative and respected Nasdaq exchange if it doesn’t get itself out of the…